Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $11.52 today, the market must believe free cash flow compounds -3.6%/yr for a decade (off $1.80B on the 3-yr avg basis).
On the basis ($1.73B) the requirement is -3.0%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's -3.6% is more conservative than its 9-yr track record.
Default is the published 10.0% — this company's own cost of capital could not be computed.
2-stage DCF · 1.61B shares (market data) · net debt -$2.58B
mean 68.0% · volatility σ 137% · implied rate exceeded in 5/9 yrs
Central path = implied -3.6%/yr growth; shaded band = ±1σ (137%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 13% of free cash flow, leaving room to grow it and fund buybacks. Last year: $333.0M dividends + $0 buybacks = $333.0M returned on $2.54B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-21
Where each multiple sits in its own 13-yr range · 69th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 13-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 7% against ROIC 7% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 77.3 | 77.8 | 75.5 | 72.4 | 71.3 | 68.2 | 67.3 | 68.5 |
| R&D | 3.6 | 3.7 | 3.3 | 3.3 | 3.7 | 4.2 | 4.7 | 5.7 |
| SG&A | 7.9 | 7.9 | 8.8 | 7.5 | 7.4 | 7.5 | 8.6 | 10.4 |
| Income Tax | 1.4 | -1.0 | 0.6 | 1.2 | 3.2 | 2.4 | 1.7 | 1.0 |
| Net Income | 3.6 | 5.1 | -3.3 | 8.8 | 8.6 | 9.2 | 6.3 | 2.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CNH: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $5.43B is below the $11.49B due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2017-12-31 (20-F).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Cash conversion and accruals. The full answer — share-based compensation, the cash conversion waterfall, working-capital trend — is still being built, so this block states what it measures rather than issuing a verdict.
One year is not a trend. The spec asks for a 3- and 5-year average of FCF/net income precisely because a single year turns on working-capital timing, and that arrives with the full Q2 block.
EOD close · as of 2026-10-21
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.09B 100.0% | $19.84B 100.0% | $24.69B 100.0% | $23.55B 100.0% | $19.50B 100.0% | $14.78B 100.0% | $28.08B 100.0% | $29.71B 100.0% | $27.70B 100.0% | $25.09B 100.0% |
| Cost of Revenue | $12.39B 68.5% | $13.35B 67.3% | $16.84B 68.2% | $16.80B 71.3% | $14.11B 72.4% | $11.15B 75.5% | $21.83B 77.8% | $22.96B 77.3% | $21.57B 77.9% | $19.42B 77.4% |
| Cost of Products | — | — | — | — | — | — | — | — | $21.62B 78.1% | $19.54B 77.9% |
| Research & Development | $1.02B 5.7% | $924.0M 4.7% | $1.04B 4.2% | $866.0M 3.7% | $642.0M 3.3% | $493.0M 3.3% | $1.03B 3.7% | $1.06B 3.6% | $957.0M 3.5% | $860.0M 3.4% |
| Selling, General & Admin | $1.88B 10.4% | $1.71B 8.6% | $1.86B 7.5% | $1.75B 7.4% | $1.45B 7.5% | $1.30B 8.8% | $2.22B 7.9% | $2.35B 7.9% | $2.31B 8.4% | $2.25B 8.9% |
| Operating Income | — | — | — | — | — | — | — | — | $1.66B 6.0% | $1.45B 5.8% |
| Interest Expense | — | — | $1.34B 5.4% | $734.0M 3.1% | $549.0M 2.8% | $660.0M 4.5% | $798.0M 2.8% | $812.0M 2.7% | $940.0M 3.4% | $1.03B 4.1% |
| Pretax Income | $620.0M 3.4% | $1.46B 7.3% | $2.70B 10.9% | $2.68B 11.4% | $1.94B 9.9% | -$179.0M -1.2% | $1.17B 4.2% | $1.47B 4.9% | $659.0M 2.4% | -$22.0M -0.1% |
| Income Tax Expense | $184.0M 1.0% | $336.0M 1.7% | $594.0M 2.4% | $747.0M 3.2% | $229.0M 1.2% | $85.0M 0.6% | -$271.0M -1.0% | $417.0M 1.4% | $457.0M 1.6% | $297.0M 1.2% |
| Net Income | $510.0M 2.8% | $1.25B 6.3% | $2.27B 9.2% | $2.03B 8.6% | $1.72B 8.8% | -$493.0M -3.3% | $1.42B 5.1% | $1.07B 3.6% | $272.0M 1.0% | -$264.0M -1.1% |
| Per Share | ||||||||||
| EPS (Basic) | $0.41 | $0.99 | $1.71 | $1.50 | $1.27 | -$0.36 | $1.05 | $0.79 | $0.20 | -$0.19 |
| EPS (Diluted) | $0.41 | $0.99 | $1.69 | $1.49 | $1.27 | -$0.36 | $1.05 | $0.78 | $0.20 | -$0.19 |
| Weighted Avg Shares (Basic) | 1.25B | 1.25B | 1.33B | 1.35B | 1.35B | 1.35B | 1.35B | 1.36B | 1.36B | 1.36B |
| Weighted Avg Shares (Diluted) | 1.25B | 1.26B | 1.35B | 1.36B | 1.36B | 1.35B | 1.35B | 1.36B | 1.37B | 1.36B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.